Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 150 Mcg (0.0150 Mg), 10 Tablets (10 X 1) Unit Dose Blisters Per Carton

Levothyroxine Sodium Tablets Recall Summary Major Pharmaceuticals is recalling 150 mcg Levothyroxine Sodium Tablets (150 mcg strength, 10-tablet unit dose blisters) distributed nationwide because the tablets contain less active ingredient than labeled. This thyroid medication recall is classified as Class II and affects products distributed across all U.S. states and Washington, D.C.

Recalling firm

Major Pharmaceuticals

Product

Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3563-0; NDC Blister: 0904-6956-61

Reason

Subpotent Drug

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-07-13

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide in the USA.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/232837a1-f29b-4b91-9ca3-46ae092df790